Article
Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
Cancer gene therapy - 1 May 2000
Heinicke T, Radziwill G, Nawrath M, Rommel C, Pavlovic J, Moelling K
Abstract excerpt
Activating mutants of ras are among the most frequently found genetic alterations in human cancers. Therefore, Ras appears to be an attractive target for therapeutic intervention using gene transfer. The protein kinase Raf-1 acts as a direct downstream effector of Ras and is involved in Ras-induced cellular transformation. Using the NIH3T3 fibroblast-derived tumor cell line PEJ, which expresses oncogenic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
